These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Phase I/II study of Fluosol-DA and 100% oxygen as an adjuvant to radiation in the treatment of advanced squamous cell tumors of the head and neck. Lustig R; McIntosh-Lowe N; Rose C; Haas J; Krasnow S; Spaulding M; Prosnitz L Int J Radiat Oncol Biol Phys; 1989 Jun; 16(6):1587-93. PubMed ID: 2722598 [TBL] [Abstract][Full Text] [Related]
4. A clinical trial of Fluosol DA 20% in advanced squamous cell carcinoma of the head and neck. Rose C; Lustig R; McIntosh N; Teicher B Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1325-7. PubMed ID: 3759553 [TBL] [Abstract][Full Text] [Related]
6. [The problem of radiogenic and chemotherapy-induced mucositis of the mouth and and oropharynx exemplified by accelerated radiochemotherapy with carboplatin in patients with inoperable squamous epithelial carcinomas of the head-/neck area. Heidelberg experiences]. Dietz A; Nollert J; Maier H; Rudat V; Flentje M HNO; 1995 Jul; 43(7):403-13. PubMed ID: 7545657 [TBL] [Abstract][Full Text] [Related]
7. Normobaric oxygen as a sensitizer in radiotherapy for advanced head and neck cancer. Zajusz A; Maciejewski B; Hliniak A Neoplasma; 1995; 42(3):137-40. PubMed ID: 7637824 [TBL] [Abstract][Full Text] [Related]
8. Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck. Haffty BG; Son YH; Wilson LD; Papac R; Fischer D; Rockwell S; Sartorelli AC; Ross D; Sasaki CT; Fischer JJ Radiat Oncol Investig; 1997; 5(5):235-45. PubMed ID: 9372546 [TBL] [Abstract][Full Text] [Related]
9. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT). Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515 [TBL] [Abstract][Full Text] [Related]
10. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience. Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834 [TBL] [Abstract][Full Text] [Related]
11. Effect of a perfluorochemical emulsion on the radiation response of BA1112 rhabdomyosarcomas. Martin DF; Porter EA; Fischer JJ; Rockwell S Radiat Res; 1987 Oct; 112(1):45-53. PubMed ID: 3116598 [TBL] [Abstract][Full Text] [Related]
12. [Effectiveness of the radiosensitizer cisplatin. A pilot study]. Klima A; Szepesi S Laryngol Rhinol Otol (Stuttg); 1987 Sep; 66(9):457-9. PubMed ID: 3683038 [TBL] [Abstract][Full Text] [Related]
13. Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer. Thorstad WL; Chao KS; Haughey B Semin Oncol; 2004 Dec; 31(6 Suppl 18):8-12. PubMed ID: 15726516 [TBL] [Abstract][Full Text] [Related]
14. Fluosol DA and oxygen as an adjuvant to the radiotherapeutic management of advanced head/neck carcinoma. Lustig RA; Rose CM; McIntosh-Lowe NL Biomater Artif Cells Artif Organs; 1988; 16(1-3):511-8. PubMed ID: 3179488 [No Abstract] [Full Text] [Related]
15. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience. Papadimitrakopoulou VA; Dimery IW; Lee JJ; Perez C; Hong WK; Lippman SM Cancer J Sci Am; 1997; 3(2):92-9. PubMed ID: 9099459 [TBL] [Abstract][Full Text] [Related]
17. Radiation treatment breaks and ulcerative mucositis in head and neck cancer. Russo G; Haddad R; Posner M; Machtay M Oncologist; 2008 Aug; 13(8):886-98. PubMed ID: 18701763 [TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy. Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501 [TBL] [Abstract][Full Text] [Related]
19. Feasibility and early results of accelerated radiotherapy for head and neck carcinoma in the elderly. Allal AS; Maire D; Becker M; Dulguerov P Cancer; 2000 Feb; 88(3):648-52. PubMed ID: 10649260 [TBL] [Abstract][Full Text] [Related]
20. Effects of Fluosol DA 20% and carbogen on the radioresponse of SCK tumors and skin of A/J mice. Lee I; Levitt SH; Song CW Radiat Res; 1987 Oct; 112(1):173-82. PubMed ID: 3116597 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]